Angela Lau

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 511 citations

Life Sciences, Immunology, Pharmacology +17

Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor

Polly Pine, Betty Chang, Nathan Schoettler et al. · Clinical Immunology · 2007 · 207 citations

Medicine, Immunology, Pharmacotherapy +16

An Acute, Double‐Blind, Placebo‐Controlled Crossover Study of 320 mg and 640 mg Doses of a Special Extract of <i>Bacopa monnieri</i> (CDRI 08) on Sustained Cognitive Performance

Luke A. Downey, James Kean, Fiona Nemeh et al. · Phytotherapy Research · 2012 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +13

Effect of nifedipine on renal function in patients with essential hypertension.

Garry P. Reams, Ann Hamory, Angela Lau et al. · Hypertension · 1988 · 58 citations

Pharmacy, Cardiology, Pharmacotherapy +17

Reliability and validity of the post COVID-19 condition stigma questionnaire: a prospective cohort study

Ronald W. Damant, Liam Rourke, Ying Cui et al. · EClinicalMedicine · 2022 · 57 citations · Full text

Health Professions, Health Sciences, Behavioral Health +12